http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0643584-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9cc2d8f832624f015bd24bec47ef697 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate | 1993-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55bd0e8aeb817110d586b3d2bffdcc9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e5c7dde360251bebfd43a202be10f74 |
| publicationDate | 1995-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0643584-A1 |
| titleOfInvention | Delivery of a cytotoxic compound to a cancer cell using a pathway of plasminogen activator material |
| abstract | A method of delivering a cytotoxic compound to a cancer cell and getting the compound inside the cancer cell using a plasminogen material such as a plasminogen activator inhibitor (PAI-1). The toxic compound is coupled to PAI-1 to form a reaction product that is coupled with urokinase plasminogen activator (uPA) that is bound to the cell surface by uPA receptors (uPAR). The resultant complex is internalized to enter the cancer cell to deliver the cytotxic compound within the cell. |
| priorityDate | 1992-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.